News
UPC
3.980
-4.56%
-0.190
Weekly Report: what happened at UPC last week (1201-1205)?
Weekly Report · 5d ago
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/04 09:48
3 Non-AI Related Dangers For The Markets In 2026
Seeking Alpha · 12/01 18:44
Weekly Report: what happened at UPC last week (1124-1128)?
Weekly Report · 12/01 10:31
The 'Real' Economy Is In Real Trouble
Seeking Alpha · 11/26 18:29
U.S. Economy: The Labor Picture Is Increasingly Murky
Seeking Alpha · 11/24 22:31
Weekly Report: what happened at UPC last week (1117-1121)?
Weekly Report · 11/24 10:37
Weekly Report: what happened at UPC last week (1110-1114)?
Weekly Report · 11/17 10:37
Weekly Report: what happened at UPC last week (1103-1107)?
Weekly Report · 11/10 10:34
Weekly Report: what happened at UPC last week (1027-1031)?
Weekly Report · 11/03 10:34
Weekly Report: what happened at UPC last week (1020-1024)?
Weekly Report · 10/27 10:39
Weekly Report: what happened at UPC last week (1013-1017)?
Weekly Report · 10/20 10:34
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 10/17 21:07
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 10/13 21:06
Weekly Report: what happened at UPC last week (1006-1010)?
Weekly Report · 10/13 10:37
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 10/09 17:06
4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings
Benzinga · 10/09 15:12
US Stocks Mixed; Nasdaq Falls Over 50 Points
Benzinga · 10/09 14:00
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 10/09 12:07
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/09 09:12
More
Webull provides a variety of real-time UPC stock news. You can receive the latest news about Universe Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About UPC
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.